(MENAFN- GlobeNewsWire - Nasdaq) Transfection Reagents & Equipment Market Growth is Driven by Advances in Gene Therapy, Rising Genetic Disease Research and High-Efficiency Delivery Methods.Austin, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Transfection Reagents & Equipment Market Size & Growth Analysis:
According to SNS Insider, the global Transfection Reagents & Equipment Market was valued at USD 1.26 billion in 2023 and is projected to reach USD 2.54 billion by 2032, expanding at a compound annual growth rate (CAGR) of 8.12% from 2024 to 2032. This growth is being driven by growing applications in gene therapy, cell biology, and drug discovery. Transfection, the process of introducing foreign genetic material into cells, has become the backbone of modern life science research. The market is expanding not only due to the increasing incidence of genetic and chronic diseases, but also due to significant technological advances that increase efficiency and scalability. As researchers push the boundaries of genome editing and personalized medicine, the demand for sophisticated, reliable transfection tools will continue to grow.
Get free Sample Report of Transfection Reagents & Equipment Market:
Transfection Reagents & Equipment Market Overview
The transfection reagents and devices market is currently a hotbed of innovation, fueled by remarkable success stories and boundless future potential. Initially known for its vaccine potential, this technology is now proving its utility in a broader therapeutic landscape. Key to this growth is the continuous improvement in delivery methods, which ensure the stability and efficacy of mRNA molecules. With major pharmaceutical players and nimble biotech startups pushing the boundaries, the dynamic nature of this market has made it a key area in modern medicine. Personalized medicine and more targeted treatments are no longer a distant dream, but a tangible reality thanks to transfection technology.
Major Players in the Transfection Reagents & Equipment Market Include:
Thermo Fisher Scientific Inc. Promega Corporation Lonza QIAGEN F. Hoffmann-La Roche Ltd. Bio-Rad Laboratories, Inc. Merck KGaA OriGene Technologies, Inc. MaxCyte Polyplus-transfection SA Aldevron Cell Biolabs Agilent Technologies Mirus Bio Vector Laboratories Dharmacon (Horizon Discovery Group)
Transfection Reagents & Equipment Market Segment Insights:
By Product
In 2023, the reagents segment led the transfection reagents and equipment market with a high revenue share of 56.1% as reagents are the key to gene expression research, protein production, and therapeutic research. The equipment segment is anticipated to experience significant growth during the forecast period on account of growing automation, improved efficiency in gene delivery, and the need for large-scale transfection systems in biomanufacturing and drug development.
By Method
The electroporation technique was the market leader in transfection reagents and equipment in 2023, due to its popularity in genetic engineering, drug discovery, and cell research. The particle bombardment process is anticipated to be the most rapidly expanding category over the forecast period based on its capability to effectively deliver genetic material into different cell types such as plant cells and difficult-to-transfect mammalian cells.
By Application
Gene expression studies accounted for the greatest revenue share in 2023 fueled by their indispensable function in elucidating genetic functions, disease mechanisms, and drug response. The segment for biomedical research is expected to register the fastest growth during the forecast period owing to growing investment in life science and medical research from the government as well as private sectors.
By End-Use
Pharmaceutical And Biotechnology became the largest segment in 2023 by utilizing transfection technologies for drug discovery, production of biopharmaceuticals, and research in gene therapy. The academic and research institutes segment is likely to experience the highest growth during the forecast period, driven by enhanced government support and private investments in life science research.
Regional Insights:
North America held the largest market share in 2023 owing to the existence of major biotechnology and pharmaceutical firms, significant government and private investment in genetic research, and extensive use of advanced transfection technologies.
The Asia Pacific region is anticipated to experience the highest growth during the forecast period, driven by growing investments in biomedical research, a developing biopharma industry, and increasing demand for sophisticated gene therapies.
Buy the Transfection Reagents & Equipment Market Report Now:
Recent Developments:
In May 2024, Merck signed a definitive agreement to acquire Mirus Bio, enhancing its position as a leading supplier in viral vector manufacturing. The acquisition strengthens Merck's upstream portfolio with Mirus Bio's transfection reagents and supports its goal of providing a fully integrated solution for gene therapies and novel modalities. In May 2024, Asimov expanded its lentivirus production portfolio by launching a new cell line development service. This addition aims to enhance viral vector manufacturing capabilities, supporting gene therapy and cell therapy applications.
Exclusive Sections of the Report (The USPs):
DISEASE INCIDENCE & PREVALENCE INSIGHTS – helps you understand the epidemiological trends driving demand for ELISA analyzers across major regions, focusing on the burden of infectious and chronic diseases that underpin diagnostic testing volumes. PRESCRIPTION PATTERN ANALYSIS – helps you identify how regional variations in prescription trends reflect diagnostic adoption, clinical testing preferences, and evolving physician behavior toward ELISA-based assays. HEALTHCARE SPENDING DISTRIBUTION – helps you evaluate the contribution of government, commercial, private, and out-of-pocket spending in shaping market growth, providing visibility into affordability, reimbursement, and healthcare accessibility. REGIONAL DIAGNOSTIC DEMAND OUTLOOK – helps you compare diagnostic infrastructure maturity and testing capacity across regions to assess future opportunities for ELISA analyzer installations and upgrades. MARKET COMPETITIVENESS INDEX – helps you gauge the strategic positioning of key manufacturers through an analysis of pricing structures, innovation focus, distribution networks, and after-sales support systems.
Transfection Reagents & Equipment Market Report Scope
| Report Attributes | Details |
| Market Size in 2023 | USD 1.26 Billion |
| Market Size by 2032 | USD 2.54 Billion |
| CAGR | CAGR of 8.12% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Key Segments | By Product [Reagents, Equipment]
By Method [Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate, DEAE-dextran, Magnetic Beads, Activated Dendrimers, Laserfection]
By Application [Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research, Biomedical Research]
By End-use [Academic And Research Institutes, Pharmaceutical And Biotechnology Companies] |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us:
Rohan Jadhav - Principal Consultant
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email:...
Comments
No comment